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Abstract 
Background: Laparoscopic cholecystectomy (LC) is the accepted standard management for benign gallbladder 
disease. LC rarely results in a diagnosis of incidental gallbladder carcinoma (IGBC). The aim of our study was to report 
our experience with IGBC diagnosed during or following LC.
Methods: Between January 2008 and January 2015, 352 patients underwent LC at Iwakuni Clinical Center. Among 
these patients, 8 (2.3%) were diagnosed with IGBC. We evaluated their characteristics, surgical related variables, histo-
pathological findings and surgical outcomes.
Results: Patient median age was 71 (range 49–88) years, and 3 out of 8 were female. All patients with IGBC were 
Japanese. The grade of cancer was as follows: pT1a (3 cases), pT2 (4 cases) and pT3 (1 case). Two patients with pT2 
disease underwent radical surgery. The median follow-up time of these patients was 24 (range 11–80) months. All 
patients are still alive and two of three patients who refused radical surgery have developed recurrence (liver metasta-
ses and recurrence in the peritoneum).
Conclusions: Although the number of cases was small, the results of this study further support the suggestion that 
gallbladder carcinoma may be curable if diagnosed as IGBC at an early stage. If the cancer has reached an advanced 
stage, radical surgery should be performed.
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Background
Gallbladder cancer (GBC) is a relatively rare neoplasm 
and is considered to be an aggressive and highly lethal 
disease. It is the most frequently occurring malignancy of 
the biliary tract and the fifth most common gastrointes-
tinal cancer [1]. Only 30% of gallbladder carcinomas are 
suspected preoperatively, and the remaining 70% are usu-
ally discovered incidentally by pathological examination 
during or after surgery [2].
In recent years, laparoscopic cholecystectomy (LC) 
has become the accepted gold standard management 
for gallbladder disease. With the advantages of a shorter 
hospital stay, decreased post-operative pain and earlier 
resumption of normal activities compared to open chol-
ecystectomy, this procedure has now become routine in 
the treatment of benign gallbladder disease worldwide. 
LC that is performed for benign gallbladder disease 
rarely results in a diagnosis of unexpected gallbladder 
carcinoma. Incidental gallbladder carcinoma (IGBC) is 
defined as carcinoma of the gallbladder suspected for the 
first time during cholecystectomy, or accidentally found 
on histological examination of gallbladder. The estimated 
incidence of IGBC diagnosed by cholecystectomy is 
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1–2% [3]. Although patients with GBC have a poor prog-
nosis, most IGBC tumors tend to be at an early stage of 
development. Hence, radical second surgery is performed 
in most patients with IGBC, and improved prognosis is 
usually reported [4–7]. However management of IGBC is 
a difficult issue in the absence of established guidelines. 
The primary aim of our study was to evaluate the inci-
dence, clinicopathological characteristics and outcome of 
patients with IGBC.
Methods
The study was approved by Ethics Committee at Iwakuni 
Clinical Center. Between January 2008 and January 2015, 
352 patients underwent LC at Iwakuni Clinical Center. 
Among these patients, 8 (2.3%) were diagnosed with 
IGBC. Their clinical presentation, ultrasonography find-
ings, preoperative diagnosis, intraoperative findings, 
histopathological records and surgical outcomes were 
reviewed. We excluded from the study all patients with 
suspected pre-operative malignancy. All LCs were exe-
cuted using the standard 4 trocar technique, and End-
Bag protected gallbladder (GB) extraction. Patients were 
staged according to the American Joint Committee on 
Cancer 7th edition tumor node metastasis clinical stag-
ing system for GBC [8]. We have advocated additional 
radical surgery for patients with pT2 or pT3 tumors [4, 5]. 
Regarding the surgical radicalization procedure, we per-
formed hepatic S4a + S5 resection with hepatic pedun-
cle lymphadenectomy [4, 5, 9]. The completeness of the 
resection was classified as follows: R0, no residuals in the 
hepatic margins; R1, a microscopically positive margin; 
and R2 macroscopic residuals in the hepatic margin.
Results
The clinical characteristics of patients with IGBC dur-
ing or following LC are detailed in Table 1. Of the eight 
patients three were female, and the median age of all 
patients was 71 (range, 49–88) years. All patients with 
IGBC were Japanese. Five patients presented with com-
plaints of pain in the right hypochondrium. Ultrasonog-
raphy revealed a thickened gallbladder in four patients 
and multiple polyps in two. Gall stones were observed 
in five patients. No patient exhibited pancreaticobiliary 
malfunction on magnetic resonance cholangiopancrea-
tography. The preoperative diagnosis of the eight patients 
with incidental IGBC was as follows: cholecystitis (2 
cases), gallbladder polyps (2 cases), gallbladder stones (4 
cases) and adenomyomatosis (2 cases). There was some 
overlapping.
The histopathological characteristics and surgical 
outcomes of IGBC patients during or following LC are 
detailed in Table 2. Intraoperatively, in one patient, there 
was a tumor suspected of being an adenocarcinoma, and 
frozen sectioning was performed; a diagnosis of adeno-
carcinoma was confirmed. The GBC was found to have 
invaded the transverse colon. Consequently, we aban-
doned open cholecystectomy with removal of cystic duct 
lymph node and performed colectomy. Also, in case with 
swelling cystic duct node, we removed it. The remain-
ing seven patients were diagnosed postoperatively on the 
basis of the histopathological examination.
According to the pathological TNM classification sys-
tem, the tumor stages were as follows: pT1a (3 cases); 
pT2 (4 cases); and pT3 (1 case). The pathological charac-
teristics of the tumors were as follows: well differentiated 
adenocarcinoma (6 cases); moderately differentiated ade-
nocarcinoma (1 case); and poorly differentiated adeno-
carcinoma (1 case).
Three patients with pT1a disease had no additional 
surgery, and there was no recurrence. Two patients with 
pT2 disease underwent radical surgery and there was no 
recurrence. The remaining three patients with pT2 dis-
ease (2 cases) or pT3 disease (1 case) refused radical sur-
gery. All patient had no adjuvant therapy (chemotherapy 
Table 1 Clinical characteristics of patients with incidental gallbladder carcinoma during or following laparoscopic chol-
ecystectomy
GB gallblader, Pre-ALP preoperative serum level of alkaline phosphatase
Patient 
number
Clinical presentation Pre-ALP 
(units/L)
Ultrasonographic finding Preoperative diagnosis
1 None 214 Multiple GB polyps GB polyp
2 Right hypochondralgia 315 Multiple GB stones GB stone
3 None 178 Multiple GB polyps GB polyp
4 Right hypochondralgia 365 Multiple GB stones GB stone, cholecystitis
5 Right hypochondralgia 272 GB wall thickening, GB stones GB stone, cholecystitis
6 None 189 Segmental GB wall thickening Adenomyomatosis
7 Right hypochondralgia 132 Segmental GB wall thickening, multiple GB stones Adenomyomatosis
8 Right hypochondralgia 313 Segmental GB wall thickening, multiple GB stones GB stone
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or chemoradiation). Follow up of both patients undergo-
ing radical surgery and refusing radical surgery is blood 
examination including tumor marker every 2 months and 
CT imaging studies every 4 months. The median follow-
up time was 24 (range 11–80) months. All patients are 
still alive and two of the three patients who refused radi-
cal surgery developed recurrence (liver metastases and 
recurrence in the peritoneum, respectively). The remain-
ing patients were disease-free during follow-up. We did 
not find any patients with port-site recurrence during the 
follow-up period. Patients with pT2/T3 received no adju-
vant chemotherapy or chemoradiation post-operatively.
Discussion
The incidence of IGBC during or after LC has been 
reported to be 0.19–3.3% [5, 10–12]. Because of the 
increased use of LC and difficulty regarding the preoper-
ative diagnosis of GBC, IGBC has become more frequent 
[11, 13]. In the present study, the rate of occurrence of 
IGBC was 2.3%.
Some studies have reported that risk factors for IGBC 
are as follows: sex (female); obesity; age >65 years; chole-
lithiasis; polypoid lesions; Asian or African American; 
and an elevated alkaline phosphatase level [14–17]. In 
our study, three patients were female and their median 
age was 64  years. All of our patients with IGBC were 
Asian. The symptoms related to IGBC can be relatively 
nonspecific, with the early symptoms mimicking those 
of GB stones or cholecystitis. GB stones are found in 
70–98% of patients with GBC. Cholelithiasis causes 
chronic irritation and inflammation of the GB, which 
leads to the development of mucosal dysplasia and sub-
sequent carcinoma; it takes a long time for the promotion 
of tumor proliferation and the occurrence of malignancy 
[18]. In our study, pain in the right hypochondrium was 
present in four patients. An additional three patient had 
no symptoms. None of our patients presented with a 
clinical profile that differed from that of typical patients 
with GB stones or cholecystitis. In the early stages, it is 
difficult to differentiate between GBC and cholecystitis, 
because thickening of the GB wall is a feature of both dis-
eases [19].
Frozen sectioning should be performed when surgeons 
suspect malignancy in intraoperative finding [20, 21]. 
In our study, the intraoperative assessment of the GB 
using frozen sections revealed GBC in one patient with 
GB wall thickening and cholecystitis. Consequently, we 
switched from LC to open cholecystectomy. The efficacy 
of frozen sections was poor with respect to the diagnosis 
of carcinoma in situ [20, 21]. Kwon et al. also found that 
diagnosis using frozen sections did not reliably detect 
the carcinoma in situ and the depth of invasion of GBC; 
thus, it should not be considered a definitive diagnostic 
procedure [22]. The most appropriate approach for diag-
nosis at present is to macroscopically examine the GB 
mucosa during surgery, and to perform frozen sectioning 
for any suspected lesion.
The survival rate of IGBC patients is high with a 
median survival rate of 21.2–60  months [5, 10, 11]. All 
patients in our studies were alive at a mean follow-up 
time of 24 months. One reason for this may be early diag-
nosis, as in the present study in which most of the cases 
involved stage 1 or 2 tumors, thereby resulting in bet-
ter prognoses. However, we could not find any common 
characteristic that could differentiate these GB carcino-
mas from benign tumors in laboratory and sonographic 
findings. The difficulty in early diagnosis of GBC results 
from its poor specificity and ambiguity regarding clini-
cal symptoms [23–25]. Tumor differentiation is an inde-
pendent prognostic factor that affects survival [5]. In the 
present study, six of eight tumors were well differentiated 
adenocarcinomas.
Surgical resection is the only curative therapy for GBC 
[15, 26, 27]. Determining the therapeutic approach for 
GBC in accordance with disease stage is supported by 
most authors [27, 28]. There is a consensus that sim-
ple cholecystectomy or LC is an adequate treatment 
for pT1a. pT2 and higher stages should be treated using 
additional radical surgery using hepatic S4a + S5 resec-
tion with hepatic peduncle lymphadenectomy [9, 15, 29, 
30]. For patients with T1b disease, the correct approach 
is still debated and some authors recommend hepatic 
gallbladder bed resection with hepatic peduncle lym-
phadenectomy [31, 32]. In the present study, the survival 
of patients with pT1 disease was favorable after LC. Two 
patients with pT2 disease underwent additional radical 
surgery and had good outcomes. Other patients with pT2 
and pT3 disease refused additional radical surgery and 
later developed recurrence.
Laparoscopic cholecystectomy appears to have resulted 
in the earlier discovery of GBC in some patients, result-
ing in an increased probability of successful treatment 
[33]. Precise surgery is essential in obtaining a good out-
come from IGBC treatment [4]. The present study was 
retrospective and involved a small number of patients. A 
study involving a considerably larger sample size will be 
required to evaluate the surgical outcome and effective-
ness of radical surgery for IGBC.
Conclusions
The incidence of IGBC detected during laparoscopic 
cholecystectomy in this single center study was found to 
be 2.3%. No association could be found with risk factors 
that have been reported by other authors. Although the 
number of patients enrolled was small, our findings fur-
ther support the suggestion that GB carcinoma may be 
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curable if diagnosed at an early stage as IGBC. pT1b or 
greater tumor stages identified on LC may benefit from 
additional radical resection.
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